1 |
Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993;106:689-95
|
2 |
Lang-Lazdunski L, Coonar AS. A prospective study of autologous 'blood patch' pleurodesis for persistent air leak after pulmonary resection. Eur J Cardiothorac Surg 2004;26:897-900
DOI
ScienceOn
|
3 |
Yoon SM, Shin SJ, Kim YC, Shon JW, Yang SC, Yoon HJ, et al. The effects of autologous blood pleurodesis in the pneumothorax with persistent air leak. Tuberc Respir Dis 2000;49:724-32
DOI
|
4 |
Chung JH, Park MS, Cheong JH, Kim YS, Chang J, Kim JH, et al. Comparison of OK-432 and doxycycline pleurodesis for malignant pleural effusions caused by lung cancer. Tuberc Respir Dis 2002;52:590-6
DOI
|
5 |
Yokomise H, Satoh K, Ohno N, Tamura K. Autoblood plus OK 432 pleurodesis with open drainage for persistent air leak after lobectomy. Ann Thorac Surg 1998;65:563-5
DOI
ScienceOn
|
6 |
Kim KU, Cha KY, Han SH, Yun YI, Park SW, Kim DJ, et al. A case of acute respiratory distress syndrome after talc pleurodesis. Tuberc Respir Dis 2001;51:265-9
DOI
|
7 |
Kim MH, Lee SH, Lee HJ, Kim KT, Lee IS, Kim HM. A case of idiopathic bilateral chylothorax treated by chemical pleurodesis with OK 432. Korean J Thorac Cardiovasc Surg 1995;28:951-3
|
8 |
Song JP, Lee JH, Kim BY, Kang KM. Pleurodesis with autologous blood plus sclerosing agents. Korean J Thorac Cardiovasc Surg 1999;32:92-5
|
9 |
Kimura I, Ohnishi T, Yasuhara S, Sugiyama M, Urabe Y. Immunochemotherapy in human lung cancer using the streptococcal agent OK-432. Cancer 1976;37:2201-3
DOI
ScienceOn
|
10 |
Kishi K, Homma S, Sakamoto S, Kawabata M, Tsuboi E, Nakata K, et al. Efficious pleurodesis with OK-432 and doxorubicin against malignat pleural effusion. Eur Respir J 2004;24:263-6
DOI
ScienceOn
|